Clinical trial NCT05681338: Effect of the Coughing Technique During Subcutaneous Heparin Injection
Official title: Effect of the Coughing Technique During Subcutaneous Heparin Injection on Pain Severity and Individual Satisfaction
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Thyroidectomy
Colon Surgery
Cholecystectomy
Inguinal Hernia
Keywords: subcutaneous heparin injection
coughing technique
pain
individual satisfaction
non-pharmacological method
Lead sponsor: Uludag University
Sponsor class: OTHER
First posted: 2023-01-12
Enrollment: 60
Sex: ALL
Minimum age (years): 22
Maximum age (years): 86
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: SEQUENTIAL
Primary purpose: TREATMENT

Brief summary: Objective: to examine the effect of the medium intensity coughing technique during subcutaneous low molecular weight heparin injection on pain severity and individual satisfaction in general surgery patients. Method: a prospective, quasi-experimental study included 100 patients who had prescribed a subcutaneous low molecular weight heparin injection once in 24 hours. Each patient received two injections by the same researcher using standard injection technique with medium intensity coughing technique and only standard injection technique.

Detailed description: Aims and objectives: The aim of this study was to examine the effect on the level of pain severity and satisfaction of patients of the medium intensity coughing technique applied to patients during the administration of subcutaneous low molecular weight heparin (LMWH) injection.

Design: This research was a prospective quasi-experimental study. Methods: It was conducted with 100 patients in the General Surgery Clinic of a university hospital in the Marmara Region of Turkey. Subcutaneous LMWH injections were administered by the same nurse to the outer side of the right and left upper arms by the standard injection technique and the medium intensity coughing technique. Immediately after the subcutaneous LMWH injection was given, a researcher who did not know which injection method had been used asked the patients to evaluate their pain levels by the Visual Analog Scale (VAS) and their satisfaction with the performance of the injection by the Visual Individual Satisfaction Scale (VISS).

Eligibility criteria: Inclusion Criteria:

* Participating voluntarily in the study
* Being over the age of 18,
* Having a doctor's prescription for subcutaneous low molecular weight heparin 0.6 mL treatment and not yet having begun treatment.
* Having no coagulation disorder, having no disorder that could affect pain perception, -
* Having no incision, lipodystrophy, or finding of infection at the injection site,
* Having no communication problem

Exclusion Criteria:

* Not wanting to participate in the study, or during the course of the research, wishing to withdraw from the study
* Having any condition which would affect the sensation of pain
* Not being able to agree on a place or time
* Being less than 18 years of age

Primary outcomes:
measure: Pain assessed by Visual Analog Scale (VAS)
timeFrame: 2 months
measure: "Satisfaction assessed by the Visual Individual Satisfaction Scale (VISS)
timeFrame: 2 months
Secondary outcomes:
measure: Weight
timeFrame: 2 months
measure: Height
timeFrame: 2 months
measure: BMI
timeFrame: 2 months
Other outcomes:
Locations:
city: Bursa
country: Turkey
facility: Bursa Uludag University Hospital
state: Nilüfer
Study officials:
References: